BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31203676)

  • 1. Systemic activation of the complement system in patients with advanced age-related macular degeneration.
    Lynch AM; Mandava N; Patnaik JL; Frazer-Abel AA; Wagner BD; Palestine AG; Mathias MT; Siringo FS; Cathcart JN; Holers VM
    Eur J Ophthalmol; 2020 Sep; 30(5):1061-1068. PubMed ID: 31203676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of systemic complement C3 activity in age-related macular degeneration.
    Sivaprasad S; Adewoyin T; Bailey TA; Dandekar SS; Jenkins S; Webster AR; Chong NV
    Arch Ophthalmol; 2007 Apr; 125(4):515-9. PubMed ID: 17420372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial and progenitor cells in age-related macular degeneration.
    Mucciolo DP; Marcucci R; Sodi A; Cesari F; Murro V; Rogolino A; Rizzo S; Giusti B; Virgili G; Prisco D; Gori AM
    Eur J Ophthalmol; 2020 Sep; 30(5):956-965. PubMed ID: 31328962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography Features Preceding the Onset of Advanced Age-Related Macular Degeneration.
    Ferrara D; Silver RE; Louzada RN; Novais EA; Collins GK; Seddon JM
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3519-3529. PubMed ID: 28715590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and Systemic Complement Activation during Anti-Vascular Endothelial Growth Factor Treatment and Age-Related Eye Disease Study 2 Dietary Supplementation in Neovascular Age-Related Macular Degeneration.
    Altay L; Lemke J; Schröder-Braunstein J; Gietzelt C; Sitnilska V; Schaub F; Cursiefen C; Enders P; Fauser S
    Ophthalmologica; 2022; 245(3):258-264. PubMed ID: 34034256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma levels of C3a complement compound in the exudative form of age-related macular degeneration.
    Machalińska A; Dziedziejko V; Mozolewska-Piotrowska K; Karczewicz D; Wiszniewska B; Machaliński B
    Ophthalmic Res; 2009; 42(1):54-9. PubMed ID: 19478542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHOROIDAL IMAGING BIOMARKERS TO PREDICT HIGHLY RESPONSIVE AND RESISTANT CASES TREATED WITH STANDARDIZED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR REGIMEN IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Jhingan M; Cavichini M; Amador M; Dans K; Bartsch DU; Cheng L; Chhablani J; Freeman WR
    Retina; 2021 Oct; 41(10):2115-2121. PubMed ID: 34543243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
    Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA
    Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Cho HJ; Park SM; Kim J; Nah SK; Lee J; Lee DW; Kim JW
    Acta Ophthalmol; 2021 Jun; 99(4):e540-e546. PubMed ID: 32996674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Activation of Lectin and Classical Pathway Complement Components in Aqueous Humor of Neovascular Age-Related Macular Degeneration.
    Omori T; Oguchi Y; Machida T; Kato Y; Ishida Y; Ojima A; Itagaki K; Shintake H; Tomita R; Kasai A; Sugano Y; Ogasawara M; Sekine H; Sekiryu T
    Ophthalmic Res; 2020; 63(3):252-258. PubMed ID: 31645047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population.
    Bonyadi M; Mohammadian T; Jabbarpoor Bonyadi MH; Fotouhi N; Soheilian M; Javadzadeh A; Moein H; Yaseri M
    Ophthalmic Genet; 2017; 38(1):61-66. PubMed ID: 27029644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local complement activation in aqueous humor in patients with age-related macular degeneration.
    Schick T; Steinhauer M; Aslanidis A; Altay L; Karlstetter M; Langmann T; Kirschfink M; Fauser S
    Eye (Lond); 2017 May; 31(5):810-813. PubMed ID: 28128795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study).
    Gillies MC; Hunyor AP; Arnold JJ; Guymer RH; Wolf S; Pecheur FL; Munk MR; McAllister IL
    Ophthalmology; 2020 Feb; 127(2):198-210. PubMed ID: 31619357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Abdelfattah NS; Zhang H; Boyer DS; Sadda SR
    Retina; 2016 Oct; 36(10):1843-50. PubMed ID: 27135213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration.
    Itty S; Day S; Lyles KW; Stinnett SS; Vajzovic LM; Mruthyunjaya P
    Retina; 2014 Sep; 34(9):1779-86. PubMed ID: 24946100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMBINING EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY AND BLOOD FLOW ANALYSIS FOR DETECTING CHOROIDAL NEOVASCULAR COMPLEXES IN PIGMENT EPITHELIAL DETACHMENTS.
    Kang H; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
    Retina; 2019 Aug; 39(8):1551-1561. PubMed ID: 29863533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.